Vancomycin Dosing and Antimicrobial Coverage

Direct Recommendation

• The Infectious Diseases Society of America recommends vancomycin dosing at 15-20 mg/kg (actual body weight) every 8-12 hours, not exceeding 2 g per dose, with a loading dose of 25-30 mg/kg for seriously ill patients 1, 2, 3

Standard Dosing Algorithm

• The American Society of Health-System Pharmacists recommends administering 15-20 mg/kg (actual body weight) every 8-12 hours for patients with normal renal function 1, 2, 3
• Traditional fixed doses of 1 g every 12 hours are inadequate for most patients and systematically underdose obese patients 2, 4

Loading Dose for Serious Infections

• The Clinical Infectious Diseases society recommends administering a loading dose of 25-30 mg/kg (actual body weight) for sepsis or septic shock, meningitis, pneumonia (especially MRSA), and infective endocarditis 1, 2, 3
• The Infectious Diseases Society of America recommends administering a loading dose of 25-30 mg/kg (actual body weight) for necrotizing fasciitis 5, 2

Therapeutic Monitoring Strategy

• The Clinical Infectious Diseases society recommends targeting trough concentrations of 15-20 μg/mL for serious infections (bacteremia, endocarditis, meningitis, pneumonia, osteomyelitis) 1, 2, 3, 4
• The American Society of Health-System Pharmacists recommends obtaining trough levels before the fourth or fifth dose at steady state 1, 2

Antimicrobial Coverage

• The Infectious Diseases Society of America recommends vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) infections, as it provides bactericidal activity against MRSA 5, 1, 3
• The Clinical Infectious Diseases society recommends vancomycin for MRSA bacteremia and endocarditis, with treatment duration of 4-6 weeks 1, 3

MIC-Based Treatment Decisions

• The Infectious Diseases Society of America recommends continuing vancomycin if the MIC is <2 μg/mL and the clinical response is adequate, but switching to an alternative agent if the MIC is ≥2 μg/mL or if there is no clinical response despite adequate source control 1, 2, 3, 4

Management of Treatment Failures

• The Clinical Infectious Diseases society recommends ensuring adequate source control, switching to high-dose daptomycin, and adding combination therapy for persistent MRSA bacteremia 1, 3, 4

Special Populations

• The American Academy of Pediatrics recommends using actual body weight for dosing calculations in obese patients, as conventional dosing systematically underdoses this population 2, 4
• The Pediatric Infectious Diseases Society recommends standard dosing of 15 mg/kg/dose every 6 hours for pediatric patients, with alternative dosing of 40-60 mg/kg/day divided every 6-8 hours depending on severity 5, 2